Bank of Nova Scotia’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.92M Buy
+47,700
New +$8.77M 0.01% 501
2025
Q1
– Sell
-39,430
Closed -$4.98M – 1115
2024
Q4
$4.98M Sell
39,430
-142,570
-78% -$21.2M 0.01% 525
2024
Q3
$30.2M Sell
182,000
-20,600
-10% -$3.12M 0.06% 188
2024
Q2
$27M Buy
202,600
+25,155
+14% +$3.03M 0.05% 222
2024
Q1
$18.7M Sell
177,445
-2,900
-2% -$261K 0.04% 282
2023
Q4
$13.6M Buy
+180,345
New +$11.4M 0.03% 358
2023
Q3
– Sell
-2,702
Closed -$220K – 1059
2023
Q2
$220K Buy
+2,702
New +$192K ﹤0.01% 947
2022
Q4
– Sell
-212,000
Closed -$10.9M – 1244
2022
Q3
$10.9M Buy
+212,000
New +$12.6M 0.03% 289

Other funds holding THC

Bank of Nova Scotia's THC Position: Q2 2026 in Review

Bank of Nova Scotia opened a new position in Tenet Healthcare (THC) in Q2 2026: 47,700 shares worth $8.92M. The stake represents 0.01% of the portfolio and ranks #501 among its holdings. This is a return to the name: Bank of Nova Scotia previously reported a position in THC as recently as Q4 2024.

Bank of Nova Scotia first reported a position in THC in Q3 2022 and has held it in 8 quarters since. The position peaked at $30.2M in Q3 2024. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Bank of Nova Scotia held 47,700 shares of Tenet Healthcare worth $8.92M as of Q2 2026.
  • Tenet Healthcare was a new Bank of Nova Scotia position in Q2 2026.
  • Tenet Healthcare made up 0.01% of Bank of Nova Scotia's portfolio in Q2 2026, its #501 holding.
  • Bank of Nova Scotia first reported a position in Tenet Healthcare in Q3 2022 and has held it in 8 quarters since.
  • Bank of Nova Scotia's Tenet Healthcare position peaked at $30.2M in Q3 2024.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.